Human infection by Babesia microti has been recognized as an emerging zoonosis with important public health implications worldwide. In Europe the reported cases of human babesiosis have been attributed mostly to B. divergens infection, with only sporadic cases of the disease caused by B. microti or B. venatorum. This study, based on molecular methods (PCR, R-T PCR, DNA sequencing and phylogenetic analysis), reveals for the first time in Poland, asymptomatic infection with B. microti in immunocompetent healthy individuals working in forest ecosystems. Of the 58 professional foresters examined, two (3.4%) were identified as B. microti-positive by specific PCR. The results of this study also provide strong evidence that in eastern Poland, where tick-borne diseases (TBDs) are endemic, there is a potential risk of acquiring human babesiosis due to zoonotic B. microti parasites commonly found in rodents and I. ricinus ticks. The potential public health importance of this finding is discussed.
INTRODUCTION
Human babesiosis is an emerging zoonotic tick-borne disease (TBD), caused by intraerthrocytic protozoa of the genus Babesia within the Piroplasmoridae [1] . It is found on all inhabited continents, with an increasing number of cases recognized every year. In some regions of the northern hemisphere, the incidence of human infections with Babesia parasites has increased dramatically in the last decade, from 4-20-fold [2] . Most reported cases in Europe have been attributed to B. divergens, and the first recorded case of infection with this species occurred in a splenectomized farmer in Croatia [3] . However, a few were caused by B. venatorum and B. microti [4] .
The primary vectors of the majority of zoonotic species of Babesia are hard exophilic ticks of the Ixodes ricinuspersulcatus 'complex' [5, 6] . A few blood transmission acquired cases of babesiosis, often caused by B. microti, have been reported in the USA [7] . Another route of Babesia transmission, which occurs sporadically, is vertical infection from mother to infant [8] . In Europe, however, B. microti is primarily transmitted by nymphs and adults of the tick I. ricinus.
Babesiosis is frequently asymptomatic in healthy immunocompetent people, but severe and often fatal cases may occur in immunodeficient individuals, especially in asplenic subjects, those of advanced age (> 50 years old), and other patients with compromised immunity [4, 9] . The clinical manifestation of babesiosis can range from subclinical infection to fulminate disease, often resulting in death [2] . Most symptomatic patients become ill 1-4 weeks after the bite of a Babesia-infected tick, or 1-9 weeks after transfusion of contaminated blood products [10] . Asymptomatic infection with low parasitemia may persist for several months or for more than a year if the infected person does not receive therapy [4] . There is a direct correlation between the immunological status of the infected person and the severity of illness they experience following babesial infection. However, clinical cases are rare, and the risk of severe babesiosis is rather low compared with other TBDs. The main symptom of babesiosis is fever, with a peak temperature of over 40 °C, which may be accompanied by chills, sweats, fatigue, headache and myalgia.
Despite the implementation of molecular analysis to study the phylogeny of Babesia parasites, the classification of B. microti parasites, which form a species 'complex' within the Piroplasmoridae with B. microti [11] as a type species, is still controversial [12, 13] .
The purpose of the presented study is to investigate the prevalence and risk of B. microti infections in healthy professional foresters working in the forest ecosystem in eastern Poland, where TBDs are endemic.
MATERIALS AND METHOD
Human sample collection and DNA isolation. A total of 58 immunocompetent individuals (41 male, 17 female, mean age 46.4, age range 20-59) were examined in early summer (June) 2011. The study participants were randomly selected forestry workers, employed in the Podlaskie province of eastern Poland. Demographic and epidemiological data were collected using a questionnaire, and blood samples taken into 1 mM EDTA for molecular analyses. Genomic DNA was extracted from whole blood using a DNAeasy Blood and Tissue Kit (Qiagen, Crawley, UK) and stored at -20 °C prior to analysis.
Polymerase chain reaction (PCR) analysis.
Detection and genotyping of Babesia isolates were performed by PCR amplification and sequencing of a fragment of the 18S rRNA gene. The primers and cycling conditions used in this study have been described previously [14] . Reactions were performed in a final volume of 20 μl containing 1 μM of each primer, 1× PCR buffer, 2 mM MgCl 2 , 0.33 mM dNTPs (Eurobio, Lille, France), 1 U Taq DNA polymerase, and 5 μl of the DNA extracted from blood samples. DNA of the Theileria sergenti, B. canis, B. ovis and B. microti King's College strain isolated from BALB/c mouse blood were used as a positive control. Template DNA was omitted from the negative control. PCR amplicons were analyzed by electrophoresis in 2% agarose gels and visualized using Midori Green stain (Nippon Genetics Europe GmbH). These DNA fragments were purified using an Axygen Clean-up purification kit (Axygen, USA) and sequenced in both directions (Genomed S.A., Poland).
Real-Time PCR (RT PCR) analysis.
Quantitative real-time PCR was used to detect the genetic material of B. microti in the DNA extracted from whole-blood specimens, employing the same primers as previously. Reactions were performed in a final volume of 20 μl and contained 0.5 μM of each primer, 2 μl of Fast Start DNA Master SYBR Green I (Roche Diagnostic, Mannheim, Germany), 2 mM MgCl 2 and 2 μl of template DNA. The amplification was performed using a LightCycler (Roche Molecular Biochemicals, Mannheim, Germany). Thirty cycles: 30 s denaturation at 95 °C, 5 s annealing at 60 °C, and 30 s extension at 72 °C were employed. The specificity of the signal was confirmed by melting curve analysis in relation to positive control samples.
Phylogenetic analysis. DNA sequence alignments and phylogenetic analysis were conducted using MEGA version 5.0 [15] . Phylogenetic trees were created using alignments performed with the Kimura-2 parameter algorithm as a distance method and NJ as the tree construction method. For comparison, sequences of Babesia, Theileria and Cytauxzoon obtained from GenBank (www.ncbi.nlm.nih.gov) were included in the sequence alignment. The stability of the inferred phylogenies was assessed by bootstrap analysis of 1,000 randomly generated sample trees.
Nucleotide sequence accession number. The partial sequence of the 18S ribosomal RNA gene of a new Babesia microti isolate (H295) was been deposited in GenBank (Accession No. KC470047).
RESULTS
Among the 58 foresters examined, in two cases (3.4%) an asymptomatic infection with B. microti was detected. These two healthy immunocompetent individuals, both over 45 years old, had been bitten several times by I. ricinus ticks while working in the forest ecosystem during the last two years. Parasites in their blood were positively identified as B. microti by PCR, RT-PCR and sequencing of the amplified 18S rRNA gene fragment.
A 560-bp fragment of 18S rRNA gene fragment was amplified by PCR using DNA isolated from the blood of the infected individuals (Fig. 1) . Phylogenetic analysis showed 100% homology of the obtained sequence with the 18S rRNA gene of B. microti Jena/Germany (EF413181), a zoonotic strain infectious to humans (Fig. 2) . The specificity and sensitivity of Babesia detection in the two identified cases were additionally confirmed by RT PCR and melting curve analysis of the amplified products (Fig. 3) . 
DISCUSSION
In the last decade of the 20th century, new tick-borne diseases (TBDs) emerged as threats to public health in Europe. These TBDs are mostly due to infections with Borrelia burgdorferi s.l., Anaplasma phagocytophilum, tick-borne encephalitis virus (TBEV) and Babesia spp: pathogens primarily transmitted by I. ricinus-persulcatus 'complex' ticks. Human babesiosis in Europe is mostly caused by B. divergens, but some have been caused by B. venatorum and B. microti. To date, approximately 40 cases have been reported, mainly in France, Ireland and the UK, with a few cases described in Sweden, Switzerland, Spain, Portugal and Croatia [6, 16, 17, 18] . To-date, only three cases of B. microti infection in humans have been reported in Europe [19, 20, 21] , one of which remains controversial [22] . Infection with B. venatorum, formally designated Babesia sp. (EU1), in Europe, was first described in two asplenic patients from Italy and Austria [23] , and two further cases have since been documented, one in a splenectomized and immunosuppressed (Rituximab) patient from Germany [24] , and the other in a person from Poland who was co-infected with Borrelia burgdorferi [25] .
The presented study, based on molecular analysis, is the first to describe asymptomatic B. microti infection without any subclinical symptoms in immunologically competent persons in Poland. Moreover, no subclinical or clinically confirmed cases of Babesia infection reported in Poland have previously been verified by molecular assays. This study demonstrates that the quantitative RT PCR assay is highly effective as a diagnostic tool for the detection of B. microti infection in whole blood.
Phylogenetic examination of the two isolates of Babesia identified in the present study, based on a Babesia 18S rRNA gene sequence, revealed their close relationship with B. microti Jena/Germany, a zoonotic strain pathogenic for humans. Both are grouped as sister clades within the piroplasms represented by Theileria annae and the other Babesia spp. of carnivores, referred to by Criado-Fornelio et al. [26] as Archaeopiroplasmids. Recently, the first genomewide phylogenetic analysis of B. microti indicated that this species is significantly distinct from species of either the Babesia or Theileria genus, and suggested that it should be classified as a new clade in the phylum Apicomplexa [12] .
Generally in Europe, there is a dearth of molecular data to confirm human cases of babesiosis, and the real prevalence in humans is probably underestimated because of subclinical infection or co-infection with other TBD pathogens, such as Borrelia burgdorferi s.l. or Anaplasma phagocytophilum. Field surveys in the north-east of Poland have shown that between 12-23% of wild rodents in forest ecosystems are infected with B. microti [27, 28] . In these ecosystems, the prevalence of infection in the abundant nymphs and adults of I. ricinus ticks was over 1%. It is noteworthy that a zoonotic genotype of B. microti (Jena strain) was recently identified in Babesiainfected ticks from this region [29] .
The findings of the presented study confirm the existence of natural foci of human babesiosis. Foresters as a group are occupationally exposed to zoonotic B. microti parasites in the Polish forest ecosystem, and thus are at potential risk of infection. 
